SLC6A3 and major depressive disorder: Moriya et al. estimated DAT availability in 11 geriatric patients with severe MDD and 27 healthy controls using PET with [18F]FE-PE2I, assuming that anhedonia, a clinical feature of geriatric patients with MDD, is associated with reduced DA neurotransmission in the reward system [66].